What is the Medicare star rating system?
Medicare’s Open Enrollment starts October 15th, but it’s not too early to think about your Medicare coverage. During open enrollment,
Read More
Part D/Prescription Drugs
Q&A: The CEO of the Alzheimer’s Association on the approval of Aduhelm — and why critics should stop dwelling on the decision
(By Andrew Joseph for STAT) Harry Johns is ready to stop talking about whether or not the Food and Drug
Read MoreMost pharmaceuticals and protective personal equipment are manufactured outside the United States.
The COVID-19 pandemic has revealed a host of problems; among them was the realization that most pharmaceuticals are manufactured outside
Read More‘I’m just winging it’: Faced with confusing data on the new Alzheimer’s drug, doctors scramble to advise their patients
(By Elizabeth Cooney for STAT) Their phones are ringing off the hook and their email inboxes are filling up with
Read More3 things to know about COVID-19 vaccine boosters
(By Erica Carbajal for Becker’s Hospital Review) Now that about 43 percent of the U.S. population has been fully vaccinated,
Read MoreFDA’s Approval of Biogen’s New Alzheimer’s Drug Has Huge Cost Implications for Medicare and Beneficiaries
(By Juliette Cubanski and Tricia Neuman for Kaiser Family Foundation published June 10, 2021) The question of what would happen when
Read MoreHow Might Lowering the Medicare Age Affect Medicaid Enrollees?
(By MaryBeth Musumeci, Robin Rudowitz, and Tricia Neuman for Kaiser Family Foundation published June 10, 2021) President Biden’s FY 2022
Read MoreLouisiana bans insurers from controversial ‘white bagging’ practice
(By Morgan Haefner for Becker’s Hospital Review) A new law in Louisiana will bar health insurers from implementing a pharmacy
Read MoreKey Facts About Medicare Part D Enrollment, Premiums, and Cost Sharing in 2021
(By Juliette Cubanski and Anthony Damico for Kaiser Family Foundation published June 8, 2021) The Medicare Part D program provides
Read MorePharma funded more than 2,400 state lawmaker campaigns in 2020, new STAT analysis finds
(By Lev Facher for STAT) WASHINGTON — State lawmakers in Oregon have tried to lower high drug prices from nearly
Read More